Related Experiment Video
Updated: Feb 27, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor
Victoria K Xie1, Zhiwei Li2, Yongmin Yan2
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract:
Purpose: The dismal prognosis of pancreatic cancer has been linked to poor tumor differentiation. However, molecular basis of pancreatic cancer differentiation and potential therapeutic value of the underlying molecules remain unknown. We investigated the mechanistic underexpression of Krüppel-like factor 4 (KLF4) in pancreatic cancer and defined a novel epigenetic pathway of its activation for pancreatic cancer differentiation and treatment.Experimental Design: Expressions of KLF4 and DNMT1 in pancreatic cancer tissues were determined by IHC and the genetic and epigenetic alterations of KLF4 in and KLF4's impact on differentiation of pancreatic cancer were examined using molecular biology techniques. The function of dietary 3,3'-diindolylmethane (DIM) on miR-152/DNMT1/KLF4 signaling in pancreatic cancer was evaluated using both cell culture and animal models.Results: Overexpression of DNMT1 and promoter hypermethylation contributed to decreased KLF4 expression in and associated with poor differentiation of pancreatic cancer. Manipulation of KLF4 expression significantly affected differentiation marker expressions in pancreatic cancer cells. DIM treatment significantly induced miR-152 expression, which blocked DNMT1 protein expression and its binding to KLF4 promoter region, and consequently reduced promoter DNA methylation and activated KLF4 expression in pancreatic cancer cells. In addition, DIM treatment caused significant inhibition of cell growth in vitro and tumorigenesis in animal models of pancreatic cancer.Conclusions: This is the first demonstration that dysregulated KLF4 expression associates with poor differentiation of pancreatic cancer. Epigenetic activation of miR-152/DNMT1/KLF4 signaling pathway by dietary DIM causes differentiation and significant growth inhibition of pancreatic cancer cells, highlighting its translational implications for pancreatic and other cancers. Clin Cancer Res; 23(18); 5585-97. ©2017 AACR.
Insights
Dietary DIM activates the miR-152/DNMT1/KLF4 pathway, promoting pancreatic cancer cell differentiation and inhibiting growth. This epigenetic approach offers new therapeutic strategies for pancreatic cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Pancreatic cancer's poor prognosis is linked to poor tumor differentiation.
- The molecular mechanisms driving pancreatic cancer differentiation and potential therapeutic targets are largely unknown.
- Krüppel-like factor 4 (KLF4) underexpression is observed in pancreatic cancer.
Purpose of the Study:
- To investigate the mechanistic basis of KLF4 underexpression in pancreatic cancer.
- To define a novel epigenetic pathway for KLF4 activation in pancreatic cancer differentiation and treatment.
- To evaluate the therapeutic potential of dietary 3,3'-diindolylmethane (DIM) in modulating this pathway.
Main Methods:
- Quantitative analysis of KLF4 and DNMT1 expression in pancreatic cancer tissues using immunohistochemistry (IHC).
- Examination of genetic and epigenetic alterations affecting KLF4 using molecular biology techniques.
- In vitro and in vivo studies using cell culture and animal models to assess DIM's effect on the miR-152/DNMT1/KLF4 signaling pathway.
Main Results:
- Increased DNMT1 expression and KLF4 promoter hypermethylation correlate with decreased KLF4 expression and poor pancreatic cancer differentiation.
- KLF4 expression levels significantly impact pancreatic cancer cell differentiation markers.
- DIM treatment upregulated miR-152, inhibited DNMT1, reduced KLF4 promoter methylation, and restored KLF4 expression.
- DIM treatment inhibited pancreatic cancer cell growth in vitro and tumorigenesis in vivo.
Conclusions:
- Dysregulated KLF4 expression is associated with poor pancreatic cancer differentiation.
- Dietary DIM epigenetically activates the miR-152/DNMT1/KLF4 signaling pathway.
- This activation leads to pancreatic cancer cell differentiation and significant growth inhibition, suggesting translational potential for pancreatic and other cancers.
Related Concept Videos
Forced Transdifferentiation
Artificial...
Abnormal Proliferation
Somatic to iPS Cell Reprogramming
Induced Pluripotent Stem Cells
Somatic...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

